FindTrial
Sign In

COVID-19 diagnostic and control methodologies based on artificial intelligence

Technological platforms for the diagnosis and control of COVID-19.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-6gdmb8c
Enrollment
Unknown
Registered
2021-05-21
Start date
2020-04-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus infection of unspecified location

Interventions

Fourier transform infrared spectroscopy (FTIR) with attenuated total reflection (ATR) is an analytical technique widely used to study molecules under different conditions. We enhanced ATR-FTIR technol
N06.850.210.275.500
E05.337.275

Sponsors

Imunoscan Engenharia Molecular LTDA
Lead Sponsor
Financiadora de Estudos e Projetos - FINEP
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Health professionals; emergency care patients; patients admitted to the infirmary; intensive care unit patients; symptomatic or asymptomatic for COVID-19.

Exclusion criteria

Exclusion criteria: Volunteers without contact with COVID-19 virus.

Design outcomes

Primary

MeasureTime frame
Fast and effective diagnosis, enabling the hospital medical system to allocate infected patients permanently, and providing early treatment.—

Secondary

MeasureTime frame
Improvement of epidemiological data in the regions involved and reduction of hospitalizations.—

Countries

Brazil

Contacts

Public ContactLuiz Ricardo Filho
lrgoulart@ufu.br+553499192-6961

Outcome results

None listed

Source: REBEC (via WHO ICTRP)